Literature DB >> 22451775

Current practices of adjunctive therapy for pertussis at six Canadian tertiary care pediatric hospitals.

C T Naugler1, S A Halperin.   

Abstract

OBJECTIVE: To document initial investigations and treatment used in the management of children hospitalized with pertussis.
DESIGN: Retrospective chart review encompassing admissions from January 1, 1991 to June 1, 1995.
SETTING: Six Canadian pediatric hospitals representing about 39% of the pediatric tertiary care beds in Canada. PATIENTS: Four hundred and forty children who met the inclusion criterion of a primary admitting diagnosis of pertussis and who did not meet the exclusion criterion of nosocomially acquired pertussis or a prior admission for pertussis during the study period. MAIN
RESULTS: Most patients had cultures positive for Bordetella pertussis, although the proportion of positive tests varied widely among hospitals. Erythromycin was the most commonly used medication; however, only 47% of children received the recommended dosage. Salbutamol and corticosteroids were used most often in patients with reactive airways disease. Younger children and those with reactive airways disease had longer lengths of stay in hospital.
CONCLUSIONS: Pertussis treatment varied widely among the six hospitals studied, and was often not consistent with current Canadian recommendations. The results will allow practitioners to place their practices in a national perspective and provide a baseline for further studies.

Entities:  

Keywords:  Adjunctive therapy; Bordetella pertussis; Pertussis; Whooping cough

Year:  1998        PMID: 22451775      PMCID: PMC3307539          DOI: 10.1155/1998/961275

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  18 in total

1.  A beta-adrenergic stimulant, salbutamol, in the treatment of pertussis.

Authors:  M K Badr-El-Din; G H Aref; A S Kassem; M A Abdel-Moneim; A A Abbassy
Journal:  J Trop Med Hyg       Date:  1976-10

2.  Randomized controlled trial of steroids in pertussis.

Authors:  I Roberts; R Gavin; D Lennon
Journal:  Pediatr Infect Dis J       Date:  1992-11       Impact factor: 2.129

3.  Treatment of severe pertussis by administration of specific gamma globulin with high titers anti-toxin antibody.

Authors:  T Ichimaru; Y Ohara; M Hojo; S Miyazaki; K Harano; T Totoki
Journal:  Acta Paediatr       Date:  1993-12       Impact factor: 2.299

4.  Evaluation of betamethasone and isoniazid along with chloramphenicol in the management of whooping cough.

Authors:  H Chandra; C S Rao; S Karan; Y C Mathur
Journal:  Indian Pediatr       Date:  1972-02       Impact factor: 1.411

5.  Pertussis: current status of prevention and treatment.

Authors:  J W Bass
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

Review 6.  Pertussis consensus conference.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1993-08-30

7.  Efficacy of salbutamol in treatment of infant pertussis demonstrated by sound spectrum analysis.

Authors:  H Peltola; K Michelsson
Journal:  Lancet       Date:  1982-02-06       Impact factor: 79.321

8.  Salbutamol vs. placebo for treatment of pertussis.

Authors:  I Krantz; S R Norrby; B Trollfors
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

9.  Salbutamol in the treatment of whooping cough.

Authors:  J Mertsola; M K Viljanen; O Ruuskanen
Journal:  Scand J Infect Dis       Date:  1986

10.  Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting.

Authors:  R W Sutter; S L Cochi
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.